Drug/Small Molecule:
terbinafine

2D structure

Overview

Generic Names: Terbinafine HCl; Terbinafine hydrochloride; Ternbinafine HCl; terbinafine
IUPAC Name: N,6,6-trimethyl-N-(naphthalen-1-ylmethyl)hept-2-en-4-yn-1-amine
Trade Names: Bramazil; Lamasil; Lamisil; Lamisil AT; Terbifoam; Terbina
PharmGKB Accession Id: PA451614

Description

Terbinafine hydrochloride (Lamisil) is a synthetic allylamine antifungal. It is highly lipophilic in nature and tends to accumulate in skin, nails, and fatty tissues. Like other allylamines, terbinafine inhibits ergosterol synthesis by inhibiting the fungal squalene epoxidase, an enzyme that is part of the fungal cell wall synthesis pathway.

Indication

For the treatment of interdigital tinea infections.

ATC Therapeutic Categories

  • D01AE:Other antifungals for topical use
  • D01BA:Antifungals for systemic use

Pharmacology and Interactions

Mechanism Of Action

Terbinafine is hypothesized to act by inhibiting squalene epoxidase, thus blocking the biosynthesis of ergosterol, an essential component of fungal cell membranes.

Pharmacology

Terbinafine is an allylamine antifungal agent and acts by inhibiting squalene epoxidase, thus blocking the biosynthesis of ergosterol, an essential component of fungal cell membranes. in vitro, mammalian squalene epoxidase is only inhibited at higher (4000 fold) concentrations than is needed for inhibition of the dermatophyte enzyme. Depending on the concentration of the drug and the fungal species test in vitro, Terbinafine may be fungicidal. However, the clinical significance of in vitro data is unknown.

Absorption, Distribution, Metabolism, Elimination & Toxicity

Biotransformation

Hepatic

Protein Binding

>99%

Absorption

Readily absorbed from gastrointestinal tract.

Half Life

36 hours

Chemical Properties

Chemical Formula:

C21H25N

SMILES Code:

CC(C)(C)C#C/C=C/CN(C)Cc1cccc2c1cccc2

(Format: OpenEye Isomeric)

Molecular Weight ( average / monoisotopic )

291.4299 / 291.1987

Curated Information

The following genes are in curated knowledge about this drug.

  Gene Relationship Evidence
Phenotype data available Genotype Data Available Literature annotations available Has annotations
CYP2D6
  •   
  •   
  •   
  •   
  • GN
Publications
Phenotype data available Genotype Data Available Literature annotations available Not annotated
CYP3A
  •   
  • PD
  • PK
  •   
  •   
Publications
Phenotype data available Genotype Data Available Literature annotations available Not annotated
NR1I2
  •   
  •   
  •   
  • FA
  •   
Publications

Non-Curated Information

A list of non-curated publications that mention this drug along with other genes is available.

Metabolizing Enzymes

Drug Targets

Curated Information

The following drugs are in curated knowledge about this drug.

  Drug Relationship Evidence
No phenotype data No genotype data Literature annotations available Not annotated
venlafaxine
  •   
  •   
  • PK
  •   
  •   
Publications

Non-Curated Information

A list of non-curated publications that mention this drug along with other drugs is available.

Drug Interactions

acenocoumarol Terbinafine decreases the anticoagulant effect
aminophylline Terbinafine increases the effect and toxicity of theophylline
anisindione Terbinafine decreases the anticoagulant effect
atomoxetine The CYP2D6 inhibitor could increase the effect and toxicity of atomoxetine
cyclosporine Terbinafine decreases the effect of cyclosporine
desipramine Terbinafine increases the effect and toxicity of the tricyclic
dextromethorphan Terbinafine increases dextromethorphan levels
dicumarol Terbinafine decreases the anticoagulant effect
dyphylline Terbinafine increases the effect and toxicity of theophylline
imipramine Terbinafine increases the effect and toxicity of the tricyclic
nortriptyline Terbinafine increases the effect and toxicity of the tricyclic
oxtriphylline Terbinafine increases the effect and toxicity of theophylline
rifampin Rifampin decreases the effect of terbinafine
theophylline Terbinafine increases the effect and toxicity of theophylline
warfarin Terbinafine decreases the anticoagulant effect

Curated Information

The following diseases are in curated knowledge about this drug.

  Disease Relationship Evidence
No phenotype data No genotype data Literature annotations available Not annotated
Toxic liver disease
  •   
  • PD
  •   
  •   
  •   
Publications

Non-Curated Information

A list of non-curated publications that mention this drug along with other diseases is available.

LinkOuts

Web Resource:
Wikipedia
DrugBank:
DB00857
KEGG Compound ID:
C08079
KEGG Drug ID:
D02375
PubChem Compound ID:
5402
PubChem Substance ID:
7849434

Common Searches

Search PubMed
Search Medline Plus
Search PubChem
Search CTD

Non-Curated Publications

A list of non-curated publications that mention this drug is available.

PharmGKB integrates drug information from different sources: DrugBank, Open Eye Scientific Software.
The PharmGKB is financially supported by the NIH/ NIGMS and is managed at Stanford University (U01GM61374).
©2001-2010 PharmGKB.